HIGHFDA DRUG
Teva Metoprolol Succinate 50 mg Extended-Release Recall 2026 Following Failed Dissolution Specs (67,
Teva Pharmaceuticals recalled 67,043 bottles of Metoprolol Succinate Extended-Release Tablets, 50 mg, distributed nationwide. The FDA enforcement report cites Failed Dissolution Specifications as the hazard. Health care providers and patients should stop using this product immediately and contact Teva for guidance.
METOPROLOL SUCCINATE
Failed Dissolution